Ontology highlight
ABSTRACT:
SUBMITTER: Cleary EG
PROVIDER: S-EPMC7787373 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
Cleary Ekaterina Galkina EG McNamee Laura M LM de Boer Skyler S Holden Jeremy J Fitzgerald Liam L Ledley Fred D FD
PloS one 20210106 1
We compared the financial performance of 319 BIOTECH companies focused on developing therapeutics with IPOs from 1997-2016, to that of paired, non-biotech CONTROL companies with concurrent IPO dates. BIOTECH companies had a distinctly different financial structure with high R&D expense, little revenue, and negative profits (losses), but a similar duration of listing on public markets and frequency of acquisitions. Through 2016, BIOTECH and CONTROL companies had equivalent growth in market cap an ...[more]